M. R. Ahmed, A. Berthet, E. Bychkov, G. Porras, Q. Li et al., Lentiviral overexpression of GRK6 alleviates L-dopainduced dyskinesia in experimental Parkinson's disease, Sci Transl Med, vol.2, pp.28-28, 2010.

I. Aubert, C. Guigoni, K. Håkansson, Q. Li, S. Dovero et al., Increased D1 dopamine receptor signaling in levodopa-induced dyskinesia, Ann Neurol, vol.57, pp.17-26, 2005.

J. Baufreton and M. D. Bevan, D2-like dopamine receptor-mediated modulation of activity-dependent plasticity at GABAergic synapses in the subthalamic nucleus, J Physiol, vol.586, pp.2121-2142, 2008.

M. Benoit-marand, M. Jaber, and F. Gonon, Release and elimination of dopamine in vivo in mice lacking the dopamine transporter: functional consequences, Eur J Neurosci, vol.12, pp.2985-2992, 2000.

A. Berthet, G. Porras, E. Doudnikoff, H. Stark, M. Cador et al., Pharmacological analysis demonstrates dramatic alteration of D1 Dopamine receptor neuronal distribution in the rat analog of L-DOPAinduced dyskinesia, J Neurosci, vol.29, pp.4829-4835, 2009.

E. Bezard, J. M. Brotchie, and C. E. Gross, Pathophysiology of levodopainduced dyskinesia: potential for new therapies, Nat Rev Neurosci, vol.2, pp.577-588, 2001.

E. Bezard, S. Dovero, C. Prunier, P. Ravenscroft, S. Chalon et al., Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease, J Neurosci, vol.21, pp.6853-6861, 2001.

E. Bézard, S. Ferry, U. Mach, H. Stark, L. Leriche et al., Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function, Nat Med, vol.9, pp.762-767, 2003.

B. Bingol and E. M. Schuman, Activity-dependent dynamics and sequestration of proteasomes in dendritic spines, Nature, vol.441, pp.1144-1148, 2006.

T. Bordia, C. Campos, L. Huang, and M. Quik, Continuous and intermittent nicotine treatment reduces L-3,4-dihydroxyphenylalanine (L-DOPA)-induced dyskinesias in a rat model of Parkinson's disease, J Pharmacol Exp Ther, vol.327, pp.239-247, 2008.

K. Brami-cherrier, E. Valjent, M. Garcia, C. Pagès, R. A. Hipskind et al., Dopamine induces a PI3-kinase-independent activation of Akt in striatal neurons: a new route to cAMP response element-binding protein phosphorylation, J Neurosci, vol.22, pp.8911-8921, 2002.
URL : https://hal.archives-ouvertes.fr/hal-02197517

M. A. Cenci and M. Lundblad, Ratings of L-DOPA-induced dyskinesia in the unilateral 6-OHDA lesion model of Parkinson's disease in rats and mice, Curr Protoc Neurosci Chapter, issue.9, p.25, 2007.

M. A. Cenci, C. S. Lee, and A. Björklund, L-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin-and glutamic acid decarboxylase mRNA, Eur J Neurosci, vol.10, pp.2694-2706, 1998.

A. Citri, G. Soler-llavina, S. Bhattacharyya, and R. C. Malenka, N-methyl-Daspartate receptor-and metabotropic glutamate receptor-dependent long-term depression are differentially regulated by the ubiquitinproteasome system, Eur J Neurosci, vol.30, pp.1443-1450, 2009.

G. C. Cotzias, P. S. Papavasiliou, and R. Gellene, Modification of Parkinsonismchronic treatment with L-dopa, N Engl J Med, vol.280, pp.337-345, 1969.

L. J. Crawford, B. Walker, H. Ovaa, D. Chauhan, K. C. Anderson et al., Comparative selectivity and specificity of the proteasome inhibitors BzLLLCOCHO, PS-341, and MG-132, Cancer Res, vol.66, pp.6379-6386, 2006.

A. Diantonio and L. Hicke, Ubiquitin-dependent regulation of the synapse, Annu Rev Neurosci, vol.27, pp.223-246, 2004.

B. Dumartin, M. Jaber, F. Gonon, M. G. Caron, B. Giros et al., Dopamine tone regulates D1 receptor trafficking and delivery in striatal neurons in dopamine transporter-deficient mice, Proc Natl Acad Sci U S A, vol.97, pp.1879-1884, 2000.

S. Fasano, E. Bezard, D. 'antoni, A. Francardo, V. Indrigo et al., Inhibition of Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1) signaling in the striatum reverts motor symptoms associated with L-dopa-induced dyskinesia, Proc Natl Acad Sci U S A, vol.107, pp.21824-21829, 2010.
URL : https://hal.archives-ouvertes.fr/hal-01055134

P. O. Fernagut, Q. Li, S. Dovero, P. Chan, T. Wu et al., Dopamine transporter binding is unaffected by L-DOPA administration in normal and MPTP-treated monkeys, Plos One, vol.5, p.14053, 2010.
URL : https://hal.archives-ouvertes.fr/hal-01055105

C. Fiorentini, C. Busi, E. Gorruso, C. Gotti, P. Spano et al., Reciprocal regulation of dopamine D1 and D3 receptor function and trafficking by heterodimerization, Mol Pharmacol, vol.74, pp.59-69, 2008.

S. Franciosi, D. Gasperi, R. Dickstein, D. L. English, D. F. Rocher et al., Pepsin pretreatment allows collagen IV immunostaining of blood vessels in adult mouse brain, J Neurosci Methods, vol.163, pp.76-82, 2007.

L. Garcia, J. Audin, D. 'alessandro, G. Bioulac, B. Hammond et al., Dual effect of high-frequency stimulation on subthalamic neuron activity, J Neurosci, vol.23, pp.8743-8751, 2003.

E. Genin, M. Reboud-ravaux, and J. Vidal, Proteasome inhibitors: recent advances and new perspectives in medicinal chemistry, Curr Top Med Chem, vol.10, pp.232-256, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00807658

B. Giros, M. Jaber, S. R. Jones, R. M. Wightman, and M. G. Caron, Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter, Nature, vol.379, pp.606-612, 1996.

S. J. Gold, C. V. Hoang, B. W. Potts, G. Porras, E. Pioli et al., RGS9-2 negatively modulates L-3,4-dihydroxyphenylalanineinduced dyskinesia in experimental Parkinson's disease, J Neurosci, vol.27, pp.14338-14348, 2007.

M. S. Goldberg, S. M. Fleming, J. J. Palacino, C. Cepeda, H. A. Lam et al., Parkindeficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons, J Biol Chem, vol.278, pp.43628-43635, 2003.

C. Guigoni, A. I. Li, Q. Gurevich, V. V. Benovic, J. L. Ferry et al., Pathogenesis of levodopainduced dyskinesia: focus on D1 and D3 dopamine receptors, pp.25-29, 2005.

C. Guigoni, Q. Li, A. I. Dovero, S. Bioulac, B. H. Bloch et al., Involvement of sensorimotor, limbic, and associative basal ganglia domains in L-3,4-dihydroxyphenylalanineinduced dyskinesia, J Neurosci, vol.25, pp.2102-2107, 2005.

C. Guigoni, E. Doudnikoff, Q. Li, B. Bloch, and E. Bezard, Altered D(1) dopamine receptor trafficking in parkinsonian and dyskinetic nonhuman primates, Neurobiol Dis, vol.26, pp.452-463, 2007.

L. Guo and Y. Wang, Glutamate stimulates glutamate receptor interacting protein 1 degradation by ubiquitin-proteasome system to regulate surface expression of GluR2, Neuroscience, vol.145, pp.100-109, 2007.

P. J. Hallett, A. W. Dunah, P. Ravenscroft, S. Zhou, E. Bezard et al., Alterations of striatal NMDA receptor subunits associated with the development of dyskinesia in the MPTPlesioned primate model of Parkinson's disease, Neuropharmacology, vol.48, pp.503-516, 2005.

P. Jenner, Molecular mechanisms of L-DOPA-induced dyskinesia, Nat Rev Neurosci, vol.9, pp.665-677, 2008.

X. Jiang, P. E. Litkowski, A. A. Taylor, Y. Lin, B. J. Snider et al., A role for the ubiquitin-proteasome system in activity-dependent presynaptic silencing, J Neurosci, vol.30, pp.1798-1809, 2010.

S. R. Jones, R. R. Gainetdinov, M. Jaber, B. Giros, R. M. Wightman et al., Profound neuronal plasticity in response to inactivation of the dopamine transporter, Proc Natl Acad Sci U S A, vol.95, pp.4029-4034, 1998.

J. K. Kane, O. Konu, J. Z. Ma, and M. D. Li, Nicotine coregulates multiple pathways involved in protein modification/degradation in rat brain, Brain Res Mol Brain Res, vol.132, pp.181-191, 2004.

A. F. Kisselev and A. L. Goldberg, Monitoring activity and inhibition of 26S proteasomes with fluorogenic peptide substrates, Methods Enzymol, vol.398, pp.364-378, 2005.

T. Kitada, S. Asakawa, N. Hattori, H. Matsumine, Y. Yamamura et al., Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism, Nature, vol.392, pp.605-608, 1998.

C. Kowalski and P. Giraud, Dopamine decreases striatal enkephalin turnover and proenkephalin messenger RNA abundance via D2 receptor activation in primary striatal cell cultures, Neuroscience, vol.53, pp.665-672, 1993.

F. J. Lee, S. Xue, L. Pei, B. Vukusic, N. Chéry et al., Dual regulation of NMDA receptor functions by direct protein-protein interactions with the dopamine D1 receptor, Cell, vol.111, pp.219-230, 2002.

S. P. Lee, C. H. So, A. J. Rashid, G. Varghese, R. Cheng et al., Dopamine D1 and D2 receptor Co-activation generates a novel phospholipase C-mediated calcium signal, J Biol Chem, vol.279, pp.35671-35678, 2004.

K. Lindsten, V. Menéndez-benito, M. G. Masucci, and N. P. Dantuma, A transgenic mouse model of the ubiquitin/proteasome system, Nat Biotechnol, vol.21, pp.897-902, 2003.

M. Lundblad, M. Andersson, C. Winkler, D. Kirik, N. Wierup et al., Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease, Eur J Neurosci, vol.15, pp.120-132, 2002.

M. Lundblad, A. Usiello, M. Carta, K. Håkansson, G. Fisone et al., Pharmacological validation of a mouse model of L-DOPA-induced dyskinesia, Exp Neurol, vol.194, pp.66-75, 2005.

M. Martin-negrier, G. Charron, and B. Bloch, Agonist stimulation provokes dendritic and axonal dopamine D(1) receptor redistribution in primary cultures of striatal neurons, Neuroscience, vol.99, pp.257-266, 2000.

M. L. Martin-negrier, G. Charron, and B. Bloch, Receptor recycling mediates plasma membrane recovery of dopamine D1 receptors in dendrites and axons after agonist-induced endocytosis in primary cultures of striatal neurons, Synapse, vol.60, pp.194-204, 2006.

W. Meissner, P. Ravenscroft, R. Reese, D. Harnack, R. Morgenstern et al., Increased slow oscillatory activity in substantia nigra pars reticulata triggers abnormal involuntary movements in the 6-OHDA-lesioned rat in the presence of excessive extracellular striatal dopamine, Neurobiol Dis, vol.22, pp.586-598, 2006.

M. H. Ossipov, I. Bazov, L. R. Gardell, J. Kowal, T. Yakovleva et al., Control of chronic pain by the ubiquitin proteasome system in the spinal cord, J Neurosci, vol.27, pp.8226-8237, 2007.

G. N. Patrick, B. Bingol, H. A. Weld, and E. M. Schuman, Ubiquitin-mediated proteasome activity is required for agonist-induced endocytosis of GluRs, Curr Biol, vol.13, pp.2073-2081, 2003.

A. C. Pawlyk, B. I. Giasson, D. M. Sampathu, F. A. Perez, K. L. Lim et al., Novel monoclonal antibodies demonstrate biochemical variation of brain parkin with age, J Biol Chem, vol.278, pp.48120-48128, 2003.

M. Quik, H. Cox, N. Parameswaran, K. O'leary, J. W. Langston et al., Nicotine reduces levodopa-induced dyskinesias in lesioned monkeys, Ann Neurol, vol.62, pp.588-596, 2007.

M. S. Raab, K. Podar, I. Breitkreutz, P. G. Richardson, and K. C. Anderson, Multiple myeloma, Lancet, vol.374, pp.324-339, 2009.
URL : https://hal.archives-ouvertes.fr/inserm-00130206

E. Santini, V. Sgambato-faure, Q. Li, M. Savasta, S. Dovero et al., Distinct changes in cAMP and extracellular signal-regulated protein kinase signalling in L-DOPA-induced dyskinesia, Plos ONE, vol.5, p.12322, 2010.
URL : https://hal.archives-ouvertes.fr/inserm-00628011

S. Schuster, A. Nadjar, J. T. Guo, Q. Li, C. Ittrich et al., The 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor lovastatin reduces severity of L-DOPA-induced abnormal involuntary movements in experimental Parkinson's disease, J Neurosci, vol.28, pp.4311-4316, 2008.

S. Schuster, E. Doudnikoff, D. Rylander, A. Berthet, A. I. Ittrich et al., Antagonizing L-type Ca 2? channel reduces development of abnormal involuntary movement in the rat model of L-3,4-dihydroxyphenylalanine-induced dyskinesia, Biol Psychiatry, vol.65, pp.518-526, 2009.

H. Shimura, N. Hattori, S. Kubo, Y. Mizuno, S. Asakawa et al., Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase, Nat Genet, vol.25, pp.302-305, 2000.

M. A. Silverdale, C. Kobylecki, P. J. Hallett, Q. Li, A. W. Dunah et al., Synaptic recruitment of AMPA glutamate receptor subunits in levodopa-induced dyskinesia in the MPTP-lesioned nonhuman primate, Synapse, vol.64, pp.177-180, 2010.

X. Sun and M. E. Wolf, Nucleus accumbens neurons exhibit synaptic scaling that is occluded by repeated dopamine pre-exposure, Eur J Neurosci, vol.30, pp.539-550, 2009.

M. E. Wolf, X. Sun, S. Mangiavacchi, and S. Z. Chao, Psychomotor stimulants and neuronal plasticity, Neuropharmacology, vol.47, pp.61-79, 2004.